Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis

Completed

• Conditions: Psoriatic Arthritis

• Registration Number: NCT00884468
• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Brief Summary

This is an epidemiological non-interventional study assessing the prevalence of anxiety and/or depression disorders in patients suffering from Psoriatic Arthritis (PsA) in Spain.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-05
• Primary Completion: 2008-12
• Study Completion: 2008-12
• Study First Submitted: 2009-04-16
• Study First Submitted QC: 2009-04-17
• Study First Posted: 2009-04-20
• Status Verified: 2009-05
• Last Update Submitted: 2009-05-26
• Last Update Posted: 2009-05-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 384

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of anxiety and/or depression disorders in patients suffering from PsA in Spain as measured by the Hospital Anxiety and Depression Scale (HAD)	12 months

Secondary Outcome Measures

Name	Time	Method
To assess the relation between the PsA severity and the presence of anxiety and/or depression disorders in patients suffering from PsA in Spain.	12 months